- Home
- NAN vs KMDA Comparison
NAN vs KMDA Comparison
Compare NAN & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAN
- KMDA
- Stock Information
- Founded
- NAN 1999
- KMDA 1990
- Country
- NAN United States
- KMDA Israel
- Employees
- NAN N/A
- KMDA N/A
- Industry
- NAN Investment Managers
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- NAN Finance
- KMDA Health Care
- Exchange
- NAN Nasdaq
- KMDA Nasdaq
- Market Cap
- NAN 353.4M
- KMDA 349.6M
- IPO Year
- NAN N/A
- KMDA N/A
- Fundamental
- Price
- NAN $11.47
- KMDA $6.45
- Analyst Decision
- NAN
- KMDA Strong Buy
- Analyst Count
- NAN 0
- KMDA 2
- Target Price
- NAN N/A
- KMDA $14.50
- AVG Volume (30 Days)
- NAN 74.6K
- KMDA 31.6K
- Earning Date
- NAN 01-01-0001
- KMDA 11-13-2024
- Dividend Yield
- NAN 4.37%
- KMDA N/A
- EPS Growth
- NAN N/A
- KMDA 124.29
- EPS
- NAN N/A
- KMDA 0.27
- Revenue
- NAN N/A
- KMDA $158,380,000.00
- Revenue This Year
- NAN N/A
- KMDA $15.38
- Revenue Next Year
- NAN N/A
- KMDA $6.18
- P/E Ratio
- NAN N/A
- KMDA $23.27
- Revenue Growth
- NAN N/A
- KMDA 4.52
- 52 Week Low
- NAN $9.11
- KMDA $4.74
- 52 Week High
- NAN $11.34
- KMDA $6.53
- Technical
- Relative Strength Index (RSI)
- NAN 54.09
- KMDA 69.61
- Support Level
- NAN $11.06
- KMDA $5.85
- Resistance Level
- NAN $11.68
- KMDA $6.09
- Average True Range (ATR)
- NAN 0.16
- KMDA 0.13
- MACD
- NAN 0.02
- KMDA 0.04
- Stochastic Oscillator
- NAN 65.97
- KMDA 99.97
About NAN Nuveen New York Quality Municipal Income Fund
Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.